Cargando…
AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model
Cyclic GMP-AMP synthase (cGAS) is an endogenous DNA sensor that synthesizes cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) from ATP and GTP. 2′3′-cGAMP activates the stimulator of interferon genes (STING) pathway, resulting in the production of interferons and pro-inflammatory c...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573294/ https://www.ncbi.nlm.nih.gov/pubmed/36235254 http://dx.doi.org/10.3390/molecules27196721 |
_version_ | 1784810833386143744 |
---|---|
author | Goswami, Avijit Deb, Barnali Goyal, Sandeep Gosavi, Abhishek Mali, Mukund Martis, Ashwita M. Khurana, Princy Gangar, Mukesh Raykar, Digambar Mohanty, Ankita Kulkarni, Aditya |
author_facet | Goswami, Avijit Deb, Barnali Goyal, Sandeep Gosavi, Abhishek Mali, Mukund Martis, Ashwita M. Khurana, Princy Gangar, Mukesh Raykar, Digambar Mohanty, Ankita Kulkarni, Aditya |
author_sort | Goswami, Avijit |
collection | PubMed |
description | Cyclic GMP-AMP synthase (cGAS) is an endogenous DNA sensor that synthesizes cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) from ATP and GTP. 2′3′-cGAMP activates the stimulator of interferon genes (STING) pathway, resulting in the production of interferons and pro-inflammatory cytokines. Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is the phosphodiesterase that negatively regulates the STING pathway by hydrolyzing 2′3′-cGAMP. It has been established that the cGAS–STING pathway plays a major role in inhibiting tumor growth by upregulating T cell response. Herein, we demonstrate that AVA-NP-695, a selective and highly potent ENPP1 inhibitor, apart from the immunomodulatory effect also modulates cancer metastasis by negatively regulating epithelial–mesenchymal transition (EMT). We established that the combined addition of 2′3′-cGAMP and AVA-NP-695 significantly abrogated the transforming growth factor beta (TGF-ꞵ)-induced EMT in MDA-MB-231 cells. Finally, results from the in vivo study showed superior tumor growth inhibition and impact on tumor metastasis of AVA-NP-695 compared to Olaparib and PD-1 in a syngeneic 4T1 breast cancer mouse model. The translation of efficacy from in vitro to in vivo 4T1 tumor model provides a strong rationale for the therapeutic potential of AVA-NP-695 against triple-negative breast cancer (TNBC) as an immunomodulatory and anti-metastatic agent. |
format | Online Article Text |
id | pubmed-9573294 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95732942022-10-17 AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model Goswami, Avijit Deb, Barnali Goyal, Sandeep Gosavi, Abhishek Mali, Mukund Martis, Ashwita M. Khurana, Princy Gangar, Mukesh Raykar, Digambar Mohanty, Ankita Kulkarni, Aditya Molecules Article Cyclic GMP-AMP synthase (cGAS) is an endogenous DNA sensor that synthesizes cyclic guanosine monophosphate–adenosine monophosphate (2′3′-cGAMP) from ATP and GTP. 2′3′-cGAMP activates the stimulator of interferon genes (STING) pathway, resulting in the production of interferons and pro-inflammatory cytokines. Ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) is the phosphodiesterase that negatively regulates the STING pathway by hydrolyzing 2′3′-cGAMP. It has been established that the cGAS–STING pathway plays a major role in inhibiting tumor growth by upregulating T cell response. Herein, we demonstrate that AVA-NP-695, a selective and highly potent ENPP1 inhibitor, apart from the immunomodulatory effect also modulates cancer metastasis by negatively regulating epithelial–mesenchymal transition (EMT). We established that the combined addition of 2′3′-cGAMP and AVA-NP-695 significantly abrogated the transforming growth factor beta (TGF-ꞵ)-induced EMT in MDA-MB-231 cells. Finally, results from the in vivo study showed superior tumor growth inhibition and impact on tumor metastasis of AVA-NP-695 compared to Olaparib and PD-1 in a syngeneic 4T1 breast cancer mouse model. The translation of efficacy from in vitro to in vivo 4T1 tumor model provides a strong rationale for the therapeutic potential of AVA-NP-695 against triple-negative breast cancer (TNBC) as an immunomodulatory and anti-metastatic agent. MDPI 2022-10-09 /pmc/articles/PMC9573294/ /pubmed/36235254 http://dx.doi.org/10.3390/molecules27196721 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Goswami, Avijit Deb, Barnali Goyal, Sandeep Gosavi, Abhishek Mali, Mukund Martis, Ashwita M. Khurana, Princy Gangar, Mukesh Raykar, Digambar Mohanty, Ankita Kulkarni, Aditya AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model |
title | AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model |
title_full | AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model |
title_fullStr | AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model |
title_full_unstemmed | AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model |
title_short | AVA-NP-695 Selectively Inhibits ENPP1 to Activate STING Pathway and Abrogate Tumor Metastasis in 4T1 Breast Cancer Syngeneic Mouse Model |
title_sort | ava-np-695 selectively inhibits enpp1 to activate sting pathway and abrogate tumor metastasis in 4t1 breast cancer syngeneic mouse model |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9573294/ https://www.ncbi.nlm.nih.gov/pubmed/36235254 http://dx.doi.org/10.3390/molecules27196721 |
work_keys_str_mv | AT goswamiavijit avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT debbarnali avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT goyalsandeep avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT gosaviabhishek avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT malimukund avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT martisashwitam avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT khuranaprincy avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT gangarmukesh avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT raykardigambar avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT mohantyankita avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel AT kulkarniaditya avanp695selectivelyinhibitsenpp1toactivatestingpathwayandabrogatetumormetastasisin4t1breastcancersyngeneicmousemodel |